Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly-Reference-Cited by-同舟云学术

Comparative efficacy and safety of MAOIs versus TCAs in treating depression in the elderly

Published:1986-10 Issue:12 Volume:21 Page:1155-1166
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Georgotas Anastasios,McCue Robert E.,worth William Hap,Friedman Eitan,Kim O.Mary,Welkowitz Joan,Chang Irene,Cooper Thomas B.

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference22 articles.

1. Relationship between plasma level and therapeutic effect of nortriptyline;Asberg;Br Med J,1971

2. Use of MAO inhibitors in elderly patients;Ashford;Am J Psychiatry,1979

3. Epidemiology of dysphoria and depression in an elderly population;Blazer;Am J Psychiatry,1980

4. Affective disorders in the elderly: Diagnostic and research considerations;Georgotas;Age Ageing,1983

5. Platelet monoamine oxidase inhibition as a potential indicator of favorable response to MAOIs in geriatric depression;Georgotas;Biol Psychiatry,1981

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beneficial and harmful effects of tricyclic antidepressants for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis;BMJ Mental Health;2024-01

2. A Review of Therapeutics for Treatment-Resistant Depression in the Older Adult;Drugs & Aging;2023-08-18

3. Psychopharmacology;The American Psychiatric Association Publishing Textbook of Geriatric Psychiatry;2022-08-09

4. Monoamine Oxidase Inhibitors in Depressive Disorders;NeuroPsychopharmacotherapy;2022

5. Nortriptyline and Maprotiline for Depressions;NeuroPsychopharmacotherapy;2022